ir@chv.vc
50 Braintree Hill Office Park Suite 301 Braintree, MA 02184
Augmenix, Inc. developed a hydrogel technology to improve outcomes in radiation oncology and surgery. These products decrease unintended radiation damage to normal organs during radiation therapy and mark soft tissue.
